Kyri K. van Hoose - 01 Sep 2021 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
Chief Financial Officer
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
Issuer symbol
DRMA
Transactions as of
01 Sep 2021
Net transactions value
$0
Form type
4
Filing time
01 Sep 2021, 20:32:02 UTC
Previous filing
14 May 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRMA Stock Option (right to Buy) Award $0 +75,000 $0.000000 75,000 01 Sep 2021 Common Stock 75,000 $5.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 48 equal monthly installments commencing October 1, 2021.